Support of existing NHSBT owned Extracorporial Photopheresis Systems

NHS Blood and Transplant · awarded 18 December 2024

£8.0m Award value £8,000,000
1 Supplier Recorded as a small or medium-sized business
31 Jan 2028 Runs until from 1 Feb 2025

Who

BuyerNHS Blood and Transplant Bristol
Supplier Therakos (UK), Ltd
Categorygoods
ClassificationMedical consumables CPV 33140000
Notice published19 December 2024

What it is for

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system's utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box. The contract award is for maintenance, training and consumables to support existing Therakos CellEx Extracorporeal Photopheresis machine platforms. This Contract is for a period of 2 years with one 12-month option to extend. Additional information: This contract has been awarded

Read the original award notice on Contracts Finder →

Other contracts from this buyer

129 awards on file, worth £216.3m.

Everything NHS Blood and Transplant has awarded →

Other contracts won by this supplier

1 award on file, worth £8.0m.

Everything Therakos (UK), Ltd has won →